Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CK1α inhibitors(casein kinase 1 alpha 1 inhibitors), IKZF2 degraders(Zinc finger protein helios degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H21N3O6 |
InChIKeyZFAKJMUJUNDGEI-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | US | 12 Dec 2023 | |
Ovarian Cancer | Preclinical | US | 12 Dec 2023 | |
Acute Myeloid Leukemia | Preclinical | US | 10 Apr 2023 |